Collective IP Analysis | BioMarin Acquisition of Prosensa


On November 24th rare disease drug maker BioMarin Pharmaceuticals¬†announced it was buying Prosensa¬†for $840MM plus approval milestones. Prosensa has no marketed products but is in the late stages of obtaining approval for its lead drug candidate, drisapersen, for a rare form of muscular dystrophy. BioMarin will pay Prosensa shareholders an additional $80MM if drisapersen receives… Read more »

What Do Business Development Executives Need to Know About the Inter Partes Review Process?

By Biz Dev Professional, Entrepreneurs. 0

There has been much discussion about inter partes review among patent professionals recently. The legal complexities can quickly multiply. The following are what we consider to be some of the very basic points that business development executives searching for patents to license need to understand about this process: What is Inter Partes Review (IPR)? ¬†Inter… Read more »

Industry:Academic Collaborations Fuel the Innovation Engine


Two mega-trends are reshaping the global biomedical research landscape: (1) In the U.S. the largest benefactor of early-stage life science research dollars is the National Institutes of Health (NIH); NIH budgets began stagnating after 2003 and declining in 2010 (2) U.S. Big Pharma has been reducing their R&D budgets consistently over the past several years;… Read more »

Google, VCs and Accelerating Discoveries out of Academic Labs


Johns Hopkins University and Google are partnering to bring ideas from the engineering school to market. While some observers may view this development as evidence that the traditional tech transfer system is failing, we view it as a positive development. We have long argued that universities are creating licensable ideas at an incredible pace, and… Read more »

Business Development Professionals and the Tech Transfer Process (Part I)


December 2015 will be the 35th anniversary of the Bayh-Dole Act. While there is active debate as to the exact numbers, the technology transfer process is acknowledged across the board (even among critics of the legislation) to have created millions of jobs, added hundreds of billions of dollars to gross domestic product, and turned university… Read more »